Skip to content Skip to footer

Sanders: Democrats’ Drug Pricing Plan “Goes Nowhere Near as Far as It Should”

Sen. Bernie Sanders suggested that pharmaceutical industry lobbying weakened the proposal.

Senate Budget Committee Chairman Bernie Sanders walks out of the U.S. Capitol after delivering a speech against the CHIPS Act on the floor of the Senate on July 25, 2022, in Washington, D.C.

Senate Budget Committee Chair Bernie Sanders on Tuesday blasted Democrats’ watered-down drug pricing plan and suggested pharmaceutical industry lobbying weakened the proposal.

“It’s a very weak proposal. It goes nowhere near as far as it should,” Sanders (I-Vt.) told NBC News’ Sahil Kapur.

The deal unveiled earlier this month would enable Medicare to negotiate the prices of a limited number of prescription drugs. Other provisions include creating a $2,000 out-of-pocket cap for Medicare Part D beneficiaries, stopping brand-name manufacturers from blocking generic options, and penalizing companies that raise prices faster than inflation.

The plan is notably backed by Sen. Joe Manchin (D-W.Va.) — who last year blocked a House-approved budget reconciliation package and said this month that he wouldn’t support new climate spending or tax hikes on the rich and large corporations.

Sanders, who pushed for a sweeping package last year and has long been a leading Medicare for All advocate, pointed to the U.S. Department of Veterans Affairs (VA) as a model for drug price negotiation.

“The American people want Medicare to negotiate prescription drug prices like the VA does,” the senator said Tuesday, according to The Hill.

“The VA has been doing that for decades. The prices they pay are about half as much as Medicare. This thing will only apply to a certain number of drugs,” Sanders continued, noting that parts of the proposal would not take effect until 2026.

“So it’s a weak proposal. Is it better than nothing? I suppose,” he added of Democrats’ plan.

Sanders also took aim at industry lobbying, specifically calling out the trade group Pharmaceutical Research and Manufacturers of America (PhRMA). As he put it: “We’re dealing with the power of PhRMA over the Congress. They don’t lose very often.”

As Common Dreams reported last week, Big Pharma is mobilizing an army of lobbyists to tank Democrats’ drug reform plan while hiking the price of prescription medications.

“Pharma is spending millions to defeat a very modest drug pricing bill,” Sanders tweeted Friday. “Joe Manchin, who is blocking climate action, is the major recipient of fossil fuel campaign contributions. This is how a corrupt political system works.”

We’re resisting Trump’s authoritarian pressure.

As the Trump administration moves a mile-a-minute to implement right-wing policies and sow confusion, reliable news is an absolute must.

Truthout is working diligently to combat the fear and chaos that pervades the political moment. We’re requesting your support at this moment because we need it – your monthly gift allows us to publish uncensored, nonprofit news that speaks with clarity and truth in a moment when confusion and misinformation are rampant. As well, we’re looking with hope at the material action community activists are taking. We’re uplifting mutual aid projects, the life-sustaining work of immigrant and labor organizers, and other shows of solidarity that resist the authoritarian pressure of the Trump administration.

As we work to dispel the atmosphere of political despair, we ask that you contribute to our journalism. Over 80 percent of Truthout’s funding comes from small individual donations from our community of readers, and over a third of our total budget is supported by recurring monthly donors.

You can help by giving today. Whether you can make a small monthly donation or a larger gift, Truthout only works with your support.